Health Impact Study of Aquatabs in Tamale, Ghana

Not Applicable

Completed

• Conditions: Diarrhea
• Interventions: Other: Placebo; Other: Sodium dichloroisocyanurate (NaDCC) tablets

• Registration Number: NCT00252928
• Lead Sponsor: Centers for Disease Control and Prevention

Brief Summary

The purpose of this study to determine whether Aquatabs, a water treatment tablet, reduces diarrheal diseases in a peri-urban population of Tamale, Ghana.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2005-11-10
• Study First Submitted QC: 2005-11-10
• Study First Posted: 2005-11-15
• Study Start: 2006-07
• Study Completion: 2006-11
• Status Verified: 2007-10
• Last Update Submitted: 2007-10-29
• Last Update Posted: 2007-10-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

• Households with at least one child under 5 years old

Exclusion Criteria

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Arm && Interventions

Group	Intervention	Description
A	Placebo	Placebo group does not receive Aquatabs.
B	Sodium dichloroisocyanurate (NaDCC) tablets	Intervention arms receives Aquatabs.

Primary Outcome Measures

Name	Time	Method
Measure the impact of Aquatabs on diarrhea among persons in households in Tamale, Ghana.	12 weeks

Secondary Outcome Measures

Name	Time	Method
Assess the microbiological quality of household water among persons living in Tamale, Ghana.	12 weeks
Determine the acceptability of Aquatabs.	12 weeks

Trial Locations

Locations (3)

Emory University Center for Global Safe Water; 🇺🇸 Atlanta, Georgia, United States

University of Development Studies; 🇬🇭 Tamale, Ghana

NewEnergy; 🇬🇭 Tamale, Ghana